File for patents to protect the intellectual property associated with the novel isocytosine derivatives. Begin the process of regulatory approval for clinical testing and eventual market release.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
N-(2-amino-6-(4-methoxyphenyl)pyrimidin-4-yl)methanesulfonamide
(R)-(+)-2-(α-(i-butyl)MethanaMine)-1H-benziMidazole, Min. 98% (R)-i-Bu-BIMAH
ACETIC ACID
7-(N-(2-methoxyphenylamino)methyl)-(20S)-camptothecin
